Publicaciones en colaboración con investigadores/as de Centro de Investigación Biomédica en Red sobre Enfermedades Neurodegenerativas (219)

2024

  1. A new mutation in the Parkinson's-related FBXO7 gene impairs mitochondrial and proteasomal function

    FEBS Journal

  2. Beneficial Effect of Dimethyl Fumarate Drug Repositioning in a Mouse Model of TDP-43-Dependent Frontotemporal Dementia

    Antioxidants, Vol. 13, Núm. 9

  3. Clearance of β-amyloid mediated by autophagy is enhanced by MTORC1 inhibition but not AMPK activation in APP/PSEN1 astrocytes

    GLIA, Vol. 72, Núm. 3, pp. 588-606

  4. Enhancing Drug Discovery and Development through the Integration of Medicinal Chemistry, Chemical Biology, and Academia-Industry Partnerships: Insights from Roche’s Endocannabinoid System Projects

    Chimia, Vol. 78, Núm. 7-8, pp. 499-512

  5. GAP43 Located on Corticostriatal Terminals Restrains Novelty-Induced Hyperactivity in Mice

    Journal of Neuroscience, Vol. 44, Núm. 39

  6. Involvement of CB1 and CB2 receptors in neuroprotective effects of cannabinoids in experimental TDP-43 related frontotemporal dementia using male mice

    Biomedicine and Pharmacotherapy, Vol. 174

  7. Protein kinase D2 modulates hepatic insulin sensitivity in male mice

    Molecular Metabolism, Vol. 90

  8. The CB1 receptor interacts with cereblon and drives cereblon deficiency-associated memory shortfalls

    EMBO Molecular Medicine, Vol. 16, Núm. 4, pp. 755-783

  9. The endocannabinoid system as a therapeutic target in neuropathic pain: a review

    Expert Opinion on Therapeutic Targets, Vol. 28, Núm. 9, pp. 739-755

  10. The mitochondrial Na+/Ca2+ exchanger NCLX is implied in the activation of hypoxia-inducible factors

    Redox Biology, Vol. 77

2023

  1. Altered Clock Gene Expression in Female APP/PS1 Mice and Aquaporin-Dependent Amyloid Accumulation in the Retina

    International Journal of Molecular Sciences, Vol. 24, Núm. 21

  2. Characterizing SOD1 mutations in Spain: The impact of genotype, age and sex in the natural history of the disease

    European Journal of Neurology, Vol. 30, Núm. 4, pp. 861-871

  3. Control of a hippocampal recurrent excitatory circuit by cannabinoid receptor-interacting protein Gap43

    Nature Communications, Vol. 14, Núm. 1

  4. Cumulative Genetic Score and C9orf72 Repeat Status Independently Contribute to Amyotrophic Lateral Sclerosis Risk in 2 Case-Control Studies

    Neurology: Genetics, Vol. 9, Núm. 4

  5. Disease-modifying effects of cannabidiol, β-caryophyllene and their combination in Syn1-Cre/Scn1aWT/A1783V mice, a preclinical model of Dravet syndrome

    Neuropharmacology, Vol. 237

  6. Elafibranor upregulates the EMT-inducer S100A4 via PPARβ/δ

    Biomedicine and Pharmacotherapy, Vol. 167

  7. Endocannabinoid signaling in glioma

    GLIA, Vol. 71, Núm. 1, pp. 127-138

  8. Endocannabinoid-Binding Receptors as Drug Targets

    Methods in molecular biology (Clifton, N.J.), Vol. 2576, pp. 67-94

  9. Fatty acids fuelling astroglia and beyond

    Nature Metabolism

  10. Functional Characterization of a Familial ALS-Associated Missense TBK1 (p-Arg573Gly) Mutation in Patient-Derived Lymphoblasts

    International Journal of Molecular Sciences, Vol. 24, Núm. 3